相关实验视频
Updated: Oct 3, 2025

09:45
On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
Published on: March 17, 2023
2.8K
通过选脂开关对ATP有反应的脂质体,这些脂质体在化代谢物结合时会发生形态变化
Jinchao Lou1, Jennifer A Schuster2, Francisco N Barrera2
1Department of Chemistry, University of Tennessee, Knoxville, Tennessee 37996, United States.
Journal of the American Chemical Society
|February 16, 2022
概括
研究人员开发出一种新型的脂质体,这种脂质体会在患病细胞中大量存在的腺三酸盐 (ATP) 的作用下释放药物. 这项突破为癌症等疾病提供了有针对性的药物治疗.
科学领域:
- 生物技术
- 药物输送系统
- 纳米医学
背景情况:
- 脂质细胞增强药物运输,但需要在疾病部位控制释放.
- 现有的触发释放策略具有有限的刺激范围.
- 在临床应用中,响应刺激的药物输送至关重要.
研究的目的:
- 开发新型的刺激反应性脂质体,用于触发内容释放.
- 调查由三氨酸 (ATP) 驱动的选择性货物释放.
- 探索疾病细胞中可控释放的新模式.
主要方法:
- 合成的脂质开关 (1a-b) 与用于ATP结合的ZnDPA单位.
- 使用染料泄漏测试 (尼罗河红色,) 来验证货物的释放.
- 使用光显微镜和ATP操纵进行细胞传递研究.
主要成果:
- 脂质体表现出由ATP引发的选择性载荷释放,而不是类似的化代谢物.
- ATP结合导致脂质交换机的形状变化,破坏了脂质体的包装.
- 细胞输送与细胞内ATP水平相关,显示特异性.
结论:
- 开发了一种新型ATP触发的脂质体系统,
- 在高ATP的存在下,可证明选择性释放和增强细胞递送.
- 这种方法提供了一个有前途的新策略,
相关概念视频
Phosphoinositides and PIPs
8.8K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.8K
Receptor-mediated Endocytosis
106.8K
Overview
106.8K

